SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-000140
Filing Date
2024-01-02
Accepted
2024-01-02 09:07:42
Documents
14
Period of Report
2024-01-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2334009d1_8k.htm   iXBRL 8-K 27091
2 EXHIBIT 99.1 tm2334009d1_ex99-1.htm EX-99.1 11017
6 GRAPHIC tm2334009d1_ex99-1img001.jpg GRAPHIC 4515
  Complete submission text file 0001104659-24-000140.txt   222639

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elan-20240102.xsd EX-101.SCH 3497
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20240102_lab.xml EX-101.LAB 35407
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20240102_pre.xml EX-101.PRE 22355
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2334009d1_8k_htm.xml XML 3207
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 24500512
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)